The clinical utility of the DeepSeek-V3 (DSV3) model in enhancing the accuracy of Liver Imaging Reporting and Data System (LI-RADS, LR) classification remains underexplored. This study aimed to evaluate the diagnostic performance of DSV3 in LR classifications compared to radiologists with varying levels of experience and to assess its potential as a decision-support tool in clinical practice. A dual-phase retrospective-prospective study analyzed 426 liver lesions (300 retrospective, 126 prospective) in high-risk HCC patients who underwent Magnetic Resonance Imaging (MRI) or Computed Tomography (CT). Three radiologists (one junior, two seniors) independently classified lesions using LR v2018 criteria, while DSV3 analyzed unstructured radiology reports to generate corresponding classifications. In the prospective cohort, DSV3 processed inputs in both Chinese and English to evaluate language impact. Performance was compared using chi-square test or Fisher's exact test, with pathology as the gold standard. In the retrospective cohort, DSV3 significantly outperformed junior radiologists in diagnostically challenging categories: LR-3 (17.8% vs. 39.7%, p<0.05), LR-4 (80.4% vs. 46.2%, p<0.05), and LR-5 (86.2% vs. 66.7%, p<0.05), while showing comparable accuracy in LR-1 (90.8% vs. 88.7%), LR-2 (11.9% vs. 25.6%), and LR-M (79.5% vs. 62.1%) classifications (all p>0.05). Prospective validation confirmed these findings, with DSV3 demonstrating superior performance for LR-3 (13.3% vs. 60.0%), LR-4 (93.3% vs. 66.7%), and LR-5 (93.5% vs. 67.7%) compared to junior radiologists (all p<0.05). Notably, DSV3 achieved diagnostic parity with senior radiologists across all categories (p>0.05) and maintained consistent performance between Chinese and English inputs. The DSV3 model effectively improves diagnostic accuracy of LR-3 to LR-5 classifications among junior radiologists . Its language-independent performance and ability to match senior-level expertise suggest strong potential for clinical implementation to standardize HCC diagnosis and optimize treatment decisions.

This study aimed to develop and validate a deep learning radiomics nomogram (DLRN) derived from ultrasound images to improve predictive accuracy for lymph node metastasis (LNM) in pancreatic cancer (PC) patients. A retrospective analysis of 249 histopathologically confirmed PC cases, including 78 with LNM, was conducted, with an 8:2 division into training and testing cohorts. Eight transfer learning models and a baseline logistic regression model incorporating handcrafted radiomic and clinicopathological features were developed to evaluate predictive performance. Diagnostic effectiveness was assessed for junior and senior ultrasound physicians, both with and without DLRN assistance. InceptionV3 showed the highest performance among DL models (AUC = 0.844), while the DLRN model, integrating deep learning and radiomic features, demonstrated superior accuracy (AUC = 0.909), robust calibration, and significant clinical utility per decision curve analysis. DLRN assistance notably enhanced diagnostic performance, with AUC improvements of 0.238 (<i>p</i> = 0.006) for junior and 0.152 (<i>p</i> = 0.085) for senior physicians. The ultrasound-based DLRN model exhibits strong predictive capability for LNM in PC, offering a valuable decision-support tool that bolsters diagnostic accuracy, especially among less experienced clinicians, thereby supporting more tailored therapeutic strategies for PC patients.

Bias field artifacts in magnetic resonance imaging (MRI) scans introduce spatially smooth intensity inhomogeneities that degrade image quality and hinder downstream analysis. To address this challenge, we propose a novel variational Hadamard U-Net (VHU-Net) for effective body MRI bias field correction. The encoder comprises multiple convolutional Hadamard transform blocks (ConvHTBlocks), each integrating convolutional layers with a Hadamard transform (HT) layer. Specifically, the HT layer performs channel-wise frequency decomposition to isolate low-frequency components, while a subsequent scaling layer and semi-soft thresholding mechanism suppress redundant high-frequency noise. To compensate for the HT layer's inability to model inter-channel dependencies, the decoder incorporates an inverse HT-reconstructed transformer block, enabling global, frequency-aware attention for the recovery of spatially consistent bias fields. The stacked decoder ConvHTBlocks further enhance the capacity to reconstruct the underlying ground-truth bias field. Building on the principles of variational inference, we formulate a new evidence lower bound (ELBO) as the training objective, promoting sparsity in the latent space while ensuring accurate bias field estimation. Comprehensive experiments on abdominal and prostate MRI datasets demonstrate the superiority of VHU-Net over existing state-of-the-art methods in terms of intensity uniformity, signal fidelity, and tissue contrast. Moreover, the corrected images yield substantial downstream improvements in segmentation accuracy. Our framework offers computational efficiency, interpretability, and robust performance across multi-center datasets, making it suitable for clinical deployment.

To explore the value of machine learning models based on MRI radiomics and automated habitat analysis in predicting bone metastasis and high-grade pathological Gleason scores in prostate cancer. This retrospective study enrolled 214 patients with pathologically diagnosed prostate cancer from May 2013 to January 2025, including 93 cases with bone metastasis and 159 cases with high-grade Gleason scores. Clinical, pathological and MRI data were collected. An nnUNet model automatically segmented the prostate in MRI scans. K-means clustering identified subregions within the entire prostate in T2-FS images. Senior radiologists manually segmented regions of interest (ROIs) in prostate lesions. Radiomics features were extracted from these habitat subregions and lesion ROIs. These features combined with clinical features were utilized to build multiple machine learning classifiers to predict bone metastasis and high-grade Gleason scores while a K-means clustering method was applied to obtain habitat subregions within the whole prostate. Finally, the models underwent interpretable analysis based on feature importance. The nnUNet model achieved a mean Dice coefficient of 0.970 for segmentation. Habitat analysis using 2 clusters yielded the highest average silhouette coefficient (0.57). Machine learning models based on a combination of lesion radiomics, habitat radiomics, and clinical features achieved the best performance in both prediction tasks. The Extra Trees Classifier achieved the highest AUC (0.900) for predicting bone metastasis, while the CatBoost Classifier performed best (AUC 0.895) for predicting high-grade Gleason scores. The interpretability analysis of the optimal models showed that the PSA clinical feature was crucial for predictions, while both habitat radiomics and lesion radiomics also played important roles. The study proposed an automated prostate habitat analysis for prostate cancer, enabling a comprehensive analysis of tumor heterogeneity. The machine learning models developed achieved excellent performance in predicting the risk of bone metastasis and high-grade Gleason scores in prostate cancer. This approach overcomes the limitations of manual feature extraction, and the inadequate analysis of heterogeneity often encountered in traditional radiomics, thereby improving model performance.

This study aimed to develop radiomic-based machine learning models using computed tomography enterography (CTE) features derived from the intestinal wall, mesenteric fat, and visceral fat to differentiate between ulcerative colitis (UC) and colonic Crohn's disease (CD). Clinical and imaging data from 116 patients with inflammatory bowel disease (IBD) (68 with UC and 48 with colonic CD) were retrospectively collected. Radiomic features were extracted from venous-phase CTE images. Feature selection was performed via the intraclass correlation coefficient (ICC), correlation analysis, SelectKBest, and least absolute shrinkage and selection operator (LASSO) regression. Support vector machine models were constructed using features from individual and combined regions, with model performance evaluated using the area under the ROC curve (AUC). The combined radiomic model, integrating features from all three regions, exhibited superior classification performance (AUC= 0.857, 95% CI, 0.732-0.982), with a sensitivity of 0.762 (95% CI, 0.547-0.903) and specificity of 0.857 (95% CI, 0.601-0.960) in the testing cohort. The models based on features from the intestinal wall, mesenteric fat, and visceral fat achieved AUCs of 0.847 (95% CI, 0.710-0.984), 0.707 (95% CI, 0.526-0.889), and 0.731 (95% CI, 0.553-0.910), respectively, in the testing cohort. The intestinal wall model demonstrated the best calibration. This study demonstrated the feasibility of constructing machine learning models based on radiomic features of the intestinal wall, mesenteric fat, and visceral fat to distinguish between UC and colonic CD.

Endoscopic ultrasound (EUS) is a vital tool for diagnosing biliopancreatic disease, offering detailed imaging to identify key abnormalities. Its interpretation demands expertise, which limits its accessibility for less trained practitioners. Thus, the creation of tools or systems to assist in interpreting EUS images is crucial for improving diagnostic accuracy and efficiency. To develop an AI-assisted EUS system for accurate pancreatic and biliopancreatic duct segmentation, and evaluate its impact on endoscopists' ability to identify biliary-pancreatic diseases during segmentation and anatomical localization. The EUS-AI system was designed to perform station positioning and anatomical structure segmentation. A total of 45,737 EUS images from 1852 patients were used for model training. Among them, 2881 images were for internal testing, and 2747 images from 208 patients were for external validation. Additionally, 340 images formed a man-machine competition test set. During the research process, various newer state-of-the-art (SOTA) deep learning algorithms were also compared. In classification, in the station recognition task, compared to the ResNet-50 and YOLOv8-CLS algorithms, the Mean Teacher algorithm achieved the highest accuracy, with an average of 95.60% (92.07%-99.12%) in the internal test set and 92.72% (88.30%-97.15%) in the external test set. For segmentation, compared to the UNet ++ and YOLOv8 algorithms, the U-Net v2 algorithm was optimal. Ultimately, the EUS-AI system was constructed using the optimal models from two tasks, and a man-machine competition experiment was conducted. The results demonstrated that the performance of the EUS-AI system significantly outperformed that of mid-level endoscopists, both in terms of position recognition (p < 0.001) and pancreas and biliopancreatic duct segmentation tasks (p < 0.001, p = 0.004). The EUS-AI system is expected to significantly shorten the learning curve for the pancreatic EUS examination and enhance procedural standardization.

Endoscopic image classification plays a pivotal role in medical diagnostics by identifying anatomical landmarks and pathological findings. However, conventional closed-set classification frameworks are inherently limited in open-world clinical settings, where previously unseen conditions can arise andcompromise model reliability. To address this, we explore the application of Open Set Recognition (OSR) techniques on the Kvasir dataset, a publicly available and diverse endoscopic image collection. In this study, we evaluate and compare the OSR capabilities of several representative deep learning architectures, including ResNet-50, Swin Transformer, and a hybrid ResNet-Transformer model, under both closed-set and open-set conditions. OpenMax is adopted as a baseline OSR method to assess the ability of these models to distinguish known classes from previously unseen categories. This work represents one of the first efforts to apply open set recognition to the Kvasir dataset and provides a foundational benchmark for evaluating OSR performance in medical image analysis. Our results offer practical insights into model behavior in clinically realistic settings and highlight the importance of OSR techniques for the safe deployment of AI systems in endoscopy.

Aimed to develop and validate a CT radiomics-based explainable machine learning model for diagnosing malignancy and benignity specifically in endometrial cancer (EC) patients. A total of 83 EC patients from two centers, including 46 with malignant and 37 with benign conditions, were included, with data split into a training set (n=59) and a testing set (n=24). The regions of interest (ROIs) were manually segmented from pre-surgical CT scans, and 1132 radiomic features were extracted from the pre-surgical CT scans using Pyradiomics. Six explainable machine learning modeling algorithms were implemented respectively, for determining the optimal radiomics pipeline. The diagnostic performance of the radiomic model was evaluated by using sensitivity, specificity, accuracy, precision, F1 score, confusion matrices, and ROC curves. To enhance clinical understanding and usability, we separately implemented SHAP analysis and feature mapping visualization, and evaluated the calibration curve and decision curve. By comparing six modeling strategies, the Random Forest model emerged as the optimal choice for diagnosing EC, with a training AUC of 1.00 and a testing AUC of 0.96. SHAP identified the most important radiomic features, revealing that all selected features were significantly associated with EC (P < 0.05). Radiomics feature maps also provide a feasible assessment tool for clinical applications. DCA indicated a higher net benefit for our model compared to the "All" and "None" strategies, suggesting its clinical utility in identifying high-risk cases and reducing unnecessary interventions. In conclusion, the CT radiomics-based explainable machine learning model achieved high diagnostic performance, which could be used as an intelligent auxiliary tool for the diagnosis of endometrial cancer.

To develop a radiomics risk-predictive model for differentiating the different stages of Hashimoto's thyroiditis (HT). Data from patients with HT who underwent definitive surgical pathology between January 2018 and December 2023 were retrospectively collected and categorized into early HT (HT patients with simple positive antibodies or simultaneously accompanied by elevated thyroid hormones) and late HT (HT patients with positive antibodies and beginning to present subclinical hypothyroidism or developing hypothyroidism). Ultrasound images and five clinical and 12 laboratory indicators were obtained. Six classifiers were used to construct radiomics models. The gradient boosting decision tree (GBDT) classifier was used to screen for the best features to explore the main risk factors for differentiating early HT. The performance of each model was evaluated by receiver operating characteristic (ROC) curve. The model was validated using one internal and two external test cohorts. A total of 785 patients were enrolled. Extreme gradient boosting (XGBOOST) showed best performance in the training cohort, with an AUC of 0.999 (0.998, 1), and AUC values of 0.993 (0.98, 1), 0.947 (0.866, 1), and 0.98 (0.939, 1), respectively, in the internal test, first external, and second external cohorts. Ultrasound radiomic features contributed to 78.6% (11/14) of the model. The first-order feature of traverse section of thyroid ultrasound image, texture feature gray-level run length matrix (GLRLM) of longitudinal section of thyroid ultrasound image and free thyroxine showed the greatest contributions in the model. Our study developed and tested a risk-predictive model that effectively differentiated HT stages to more precisely and actively manage patients with HT at an earlier stage.

The therapeutic management of neoplasm employs high level energy beam to ablate malignant cells, which can cause collateral damage to adjacent normal tissue. Furthermore, respiration-induced organ motion, during radiotherapy can lead to significant displacement of neoplasms. In this work, a non-invasive ultrasound-based deep learning algorithm for respiratory motion compensation system (RMCS) was developed to mitigate the effect of respiratory motion induced neoplasm movement in radiotherapy. The deep learning algorithm generated based on modified YOLOv8n (You Only Look Once), by incorporating squeeze and excitation blocks for channel wise recalibration and enhanced attention mechanisms for spatial channel focus (SE-ATT-YOLO) to cope up with enhanced ultrasound image detection in real time scenario. The trained model was inferred with ultrasound movement of human diaphragm and tracked the bounding box coordinates using BoT-Sort, which drives the RMCS. The SE-ATT-YOLO model achieved mean average precision (mAP) of 0.88 which outperforms YOLOv8n with the value of 0.85. The root mean square error (RMSE) obtained from prerecorded respiratory signals with the compensated RMCS signal was calculated. The model achieved an inference speed of approximately 50 FPS. The RMSE values recorded were 4.342 for baseline shift, 3.105 for sinusoidal signal, 1.778 for deep breath, and 1.667 for slow signal. The SE-ATT-YOLO model outperformed all the results of previous models. The loss function uncertainty in YOLOv8n model was rectified in SE-ATT YOLO depicting the stability of the model. The model' stability, speed and accuracy of the model optimized the performance of the RMCS.